No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 6.010
- -0.410-6.39%
Close Jan 8 16:00 ET
- 6.150
- +0.140+2.33%
Post 17:26 ET
508.83MMarket Cap-2.44P/E (TTM)
6.400High5.995Low1.33MVolume6.290Open6.420Pre Close8.08MTurnover2.39%Turnover RatioLossP/E (Static)84.66MShares19.34052wk High1.00P/B336.17MFloat Cap4.30552wk Low--Dividend TTM55.94MShs Float78.000Historical High--Div YieldTTM6.31%Amplitude4.305Historical Low6.053Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Verve Therapeutics, Inc. (VERV): Is This Gene Therapy Stock a Good Buy Right Now?
Verve Therapeutics Slides As Insider Purchases Lose Another US$65k
Stifel Maintains Verve Therapeutics(VERV.US) With Buy Rating
Stifel Nicolaus Sticks to Their Buy Rating for Verve Therapeutics (VERV)
One Verve Therapeutics Insider Raised Stake By 29% In Previous Year
Heat List
US
Overall
Symbol
Price
% Chg
No Data